Skip Navigation

European Journal of Heart Failure 2009 11(12):1155-1162; doi:10.1093/eurjhf/hfp147
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Eur J Heart Fail
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Al-Najjar, Y.
Right arrow Articles by Clark, A. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Najjar, Y.
Right arrow Articles by Clark, A. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure

Yahya Al-Najjar*, Kevin M. Goode, Jufen Zhang, John G.F. Cleland and Andrew L. Clark

Department of Cardiology, Division of Cardiovascular and Respiratory Studies, Postgraduate Medical Institute, Castle Hill Hospital, 1st Floor, Medical Research Building, Entrance 2, Castle Road, Kingston-upon-Hull, East Yorkshire HU16 5JQ, UK

* Corresponding author. Tel: +44 1482 461 782, Fax: +44 1482 461 808, Email: ys.najjar{at}gmail.com


   Abstract

Aims: Red cell distribution width (RDW) is prognostic in patients with heart failure (HF), but it has not been compared with N-terminal brain natriuretic peptide (NT-proBNP). We sought to make this comparison.

Methods and results: Patients referred to a specialist HF clinic between 2001 and 2008 were assessed comprehensively including medical history, echocardiogram, and blood tests. Cox-regression was used to assess the multivariable relationship between RDW, NT-proBNP, and all-cause mortality. A total of 1087 patients were recruited; median (IQR) follow-up was 52 months (29–66); age 72 years (64–78); 74% male; 70% ischaemic heart disease; 20% diabetic; 85% NYHA ≥ 2, and 63% with at least moderate LV impairment (EF < 35% equivalent). In a multivariable model, both RDW and NT-proBNP were independently prognostic (RDW: {chi}2 = 21.8 vs. 49.1 both P < 0.001). In a model using quartiles of each variable, the relative risk for each was similar for the second and third quartiles compared with the first. A larger increase in risk for NT-proBNP is seen in the fourth quartile.

Conclusion: Red cell distribution width is a readily available test in the HF-population with similar independent prognostic power to NT-proBNP across the first to third quartiles. Prognostic models in HF should include RDW and further investigation is necessary to determine the pathological mechanism of the relationship.

Key Words: Heart failure • Red cell distribution width • NT-proBNP • Markers • Prognosis

Received August 7, 2009; Revised September 4, 2009; Accepted September 7, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Eur J Heart Fail:

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure
Colette E. Jackson, Jonathan R. Dalzell, Vladimir Bezlyak, Ioannis K. Tsorlalis, Rachel C. Myles, Richard Spooner, Ian Ford, Mark C. Petrie, Stuart M. Cobbe, and John J.V. McMurray
Eur J Heart Fail 2009 11: 1152-1154. [Extract] [Full Text]  





Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.